ArticleFamilial cancer2026
Exploration of familial genetic test result communication among Black women within an academic safety net hospital.
Article in Familial cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Individuals who receive a pathogenic result from hereditary cancer genetic testing face challenges effectively sharing this information with their relatives, leading to low rates of familial cascade testing. Communication of a cancer predisposition and subsequent familial testing is important, so at-risk relatives can receive appropriate medical screenings and risk-reducing interventions. While barriers and facilitators to cascade testing have been explored primarily among individuals who are White and report higher incomes, they have not been thoroughly assessed among other groups. This study explored the experiences of Black women sharing their pathogenic cancer genetic test results with their relatives. All eight participants had received genetic counseling and testing at Grady Memorial Hospital, an academic safety net hospital in Atlanta, Georgia. Participants completed semi-structured interviews about barriers and facilitators they experienced while disclosing their genetic test results to relatives. Interviews were independently coded amongst two coders (RA/JP), thematic content analysis was performed, and a pooled Cohen’s Kappa of 0.69 was obtained. Notable barriers to disclosure included distrust in the accuracy of genetic testing results and misconceptions such as perm products causing heritable gene mutations. Unique facilitators of cascade testing include feelings of empowerment and reliance on personal faith as a coping strategy before sharing results. Participants provided suggestions to improve the cascade testing process, such as family result sessions and community awareness events. Genetic counselors can utilize these unique facilitators and barriers to cascade testing to provide culturally appropriate care and to improve communication of results among families receiving hereditary cancer testing.
Indexed as
Identifiers
41615528What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.